Phase I multiple ascending dose trial of CNV 2197944 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2012
At a glance
- Drugs CNV 2197944 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 18 Jul 2012 Results have been reported in a Convergence Pharmaceuticals media release.
- 18 Jul 2012 Status changed from recruiting to completed based on information reported in a Convergence Pharmaceuticals media release.
- 23 Nov 2011 New trial record